PROCEPT BioRobotics (PRCT)
(Delayed Data from NSDQ)
$52.48 USD
-1.27 (-2.36%)
Updated Apr 24, 2024 04:00 PM ET
After-Market: $52.49 +0.01 (0.02%) 7:58 PM ET
3-Hold of 5 3
D Value F Growth B Momentum F VGM
Price, Consensus and EPS Surprise
PRCT 52.48 -1.27(-2.36%)
Will PRCT be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for PRCT based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for PRCT
Accelerate Diagnostics (AXDX) Reports Q4 Loss, Misses Revenue Estimates
Masimo (MASI) Soars 3.3%: Is Further Upside Left in the Stock?
PRCT: What are Zacks experts saying now?
Zacks Private Portfolio Services
Is SPDR S&P Health Care Equipment ETF (XHE) a Strong ETF Right Now?
Teleflex (TFX) Q4 Earnings and Revenues Surpass Estimates
Earnings Preview: Integra LifeSciences (IART) Q4 Earnings Expected to Decline
Other News for PRCT
PROCEPT BioRobotics Announces 12 Scientific Research Presentations on Aquablation Therapy for the Treatment of Benign Prostatic Hyperplasia at the 2024 AUA Annual Meeting
Procept BioRobotics announces 12 scientific research presentations
PROCEPT BioRobotics Announces Board Member Transition
PROCEPT BioRobotics Corp. Announces Investor Event at 2024 AUA Annual Meeting in San Antonio, Texas
PROCEPT BioRobotics to Report First Quarter 2024 Financial Results on May 1, 2024 and Attend the 2024 Bank of America Healthcare Conference on May 15, 2024